Publication details
Efficacy Of Thalidomide-Based And Bortezomib-Based Regimens In The First Relapse Of 146 Multiple Myeloma Patients: A Single Centre Experience
| Authors | |
|---|---|
| Year of publication | 2010 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | The thalidomide-based and bortezomib-based regimens are effective in treatment of the first relapse MM with ORR 45-56%. Medians of TTP and OS are similar for both treatment groups, combination of novel agent with other drugs (dexamethason and/or alkylating agent) seems to be very useful. However, the significance part of patients (37-38%) had progression on this treatment and other treatment strategies are needed. |